Fiduciary Trust International’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,760
Closed -$209K 143
2019
Q3
$209K Buy
+2,760
New +$189K 0.04% 124
2019
Q2
Sell
-4,739
Closed -$449K 129
2019
Q1
$449K Buy
4,739
+580
+14% +$47.4K 0.11% 70
2018
Q4
$383K Sell
4,159
-553
-12% -$48.6K 0.12% 75
2018
Q3
$446K Buy
4,712
+338
+8% +$32.1K 0.13% 73
2018
Q2
$405K Sell
4,374
-258
-6% -$25.2K 0.12% 74
2018
Q1
$438K Buy
4,632
+817
+21% +$89.7K 0.11% 72
2017
Q4
$369K Buy
3,815
+1,420
+59% +$134K 0.09% 72
2017
Q3
$213K Buy
+2,395
New +$182K 0.05% 101
2015
Q1
Sell
-3,078
Closed -$201K 107
2014
Q4
$201K Buy
+3,078
New +$194K 0.06% 125

Other funds holding ABBV

Fiduciary Trust International's ABBV Position: Q4 2019 in Review

Fiduciary Trust International sold out of AbbVie (ABBV) in Q4 2019, closing a stake of 2,760 shares — an estimated $209K sold.

Fiduciary Trust International first reported a position in ABBV in Q4 2014 and held it in 9 quarters. The position peaked at $449K in Q1 2019. 2,243 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

  • Fiduciary Trust International reported no remaining AbbVie position as of Q4 2019 after selling out during the quarter.
  • Fiduciary Trust International sold 2,760 AbbVie shares in Q4 2019, an estimated $209K.
  • Fiduciary Trust International first reported a position in AbbVie in Q4 2014 and held it in 9 quarters.
  • Fiduciary Trust International's AbbVie position peaked at $449K in Q1 2019.
  • 2,243 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on Fiduciary Trust International's 13F filing for Q4 2019, filed 10 Feb 2020.